Ruken Dayanan
ORCID: 0000-0002-8192-8841
· 1 paper in corpus
other
2025
OBJECTIVE: To evaluate the diagnostic utility of advanced oxidation protein products (AOPPs), calprotectin, and classical tumor markers (CA 125 and CA19-9) in distinguishing ovarian endometriomas from simple cysts and healthy controls, as w…